Tennessee 114th General Assembly Status: Enacted Bipartisan · 2 R · 2 D cosponsors

SB 0421 — AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.

Last action — Comp. became Pub. Ch. 295

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 28, 2025. Enacted.

Signed by Governor Bill Lee (Republican) on April 10, 2025.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 94% · high confidence

  • Enacted

    Current position in the legislative process.

  • 4 sponsors

    1 primary, 3 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (2 R · 2 D) — cross-party backing.

  • Cleared a recorded vote

    Passed 2 recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Bill Text

Action History

  1. Filed for introduction

  2. Intro., P1C.

  3. P2C, ref. to Health Committee

  4. Assigned to s/c Health Subcommittee

  5. Placed on s/c cal Health Subcommittee for 3/19/2025

  6. Rec for pass if am by s/c ref. to Health Committee

  7. Placed on cal. Health Committee for 3/25/2025

  8. Action def. in Health Committee to 4/1/2025

  9. Placed on cal. Health Committee for 4/1/2025

  10. Rec. for pass. if am., ref. to Calendar & Rules Committee

  11. Placed on cal. Calendar & Rules Committee for 4/3/2025

  12. H. Placed on Regular Calendar for 4/7/2025

  13. H. adopted am. (Amendment 1 - HA0252)

  14. Sponsor(s) Added.

  15. Passed H., as am., Ayes 92, Nays 1, PNV 0

  16. Engrossed; ready for transmission to Sen.

  17. Received from House, Passed on First Consideration

  18. Senate substituted House Bill for companion Senate Bill.

  19. Amendment withdrawn. (Amendment 1 - SA0095)

  20. Passed Senate, Ayes 27, Nays 4

  21. Enrolled; ready for sig. of H. Speaker.

  22. Signed by H. Speaker

  23. Signed by Senate Speaker

  24. Transmitted to Governor for his action.

  25. Signed by Governor.

  26. Pub. Ch. 295

  27. Effective date(s) 07/01/2025

  28. Filed for introduction

  29. Introduced, Passed on First Consideration

  30. Passed on Second Consideration, refer to Senate Judiciary Committee

  31. Placed on Senate Judiciary Committee calendar for 2/25/2025

  32. Action deferred in Senate Judiciary Committee to 3/11/2025

  33. Placed on Senate Judiciary Committee calendar for 3/11/2025

  34. Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0

  35. Placed on Senate Regular Calendar for 3/17/2025

  36. Senate Reset on calendar for 3/27/2025

  37. Placed on Senate Regular Calendar for 3/24/2025

  38. Senate Reset on calendar for 3/31/2025

  39. Sponsor(s) Added.

  40. Placed on Senate Regular Calendar for 3/31/2025

  41. Senate Reset on calendar for 4/3/2025

  42. Sponsor(s) Added.

  43. Placed on Senate Regular Calendar for 4/3/2025

  44. Senate Reset on calendar for 4/7/2025

  45. Placed on Senate Regular Calendar for 4/7/2025

  46. Companion House Bill substituted

  47. Sponsor(s) Added.

  48. Comp. became Pub. Ch. 295

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 3 co-sponsors · 129 not signed on

Sponsors (1)

Co-sponsors (3)

Not signed on (129)

129 members have not signed on to this bill.

Show all 129 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 0421 do?
Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
Who sponsors SB 0421?
SB 0421 is sponsored by Reeves, Shane (Republican), Yarbro, Jeff (Democrat), Campbell, Heidi (Democrat), and Jackson, Ed (Republican).
What is the current status of SB 0421?
This bill has been enacted into law. Introduced January 28, 2025. Enacted.
Where can I track SB 0421?
Track SB 0421 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 0421

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 0421

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →